Mohammad A. Alzubi

Also affiliated with University of Baltimore

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer”.

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-3484

N/A

0DataRank · unranked

12 citations

Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt +11 more

PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny

Cancer Immunology Immunotherapy(2025)10.1007/s00262-024-03939-4

N/A

0DataRank · unranked

1 citations

Theresa J. Barberi, Alan D. Friedman, Mohammad A. Alzubi